Abstract
The mouse lymphoma assay (MLA) quantifies genetic alterations affecting expression of the thymidine kinase (Tk) gene which is located on chromosome 11. This assay is widely used for evaluating the genotoxic potential of various agents. It can also be used for photo-mutagenicity. The Tk-deficient mutants in the MLA result not only from point mutations but also from gross structural and numerical changes at the chromosomal level. The MLA has been recommended as one component of the genotoxicity test battery in many regulatory authorities, countries, and international organizations. The protocol for the MLA has been optimized and adopted by many laboratories around the world. In this chapter, the authors provide an example of the application of the MLA by detailing the procedures that are used for performing the assay in their laboratory and analyzing and interpreting the data generated from both the soft-agar and microwell versions of the assay. In addition, they provide information for using the assay for the analysis of potential photo-mutagenicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Clive D, Flamm WG, Machesko MR, Bernheim NJ (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat Res 16:77–87
Cole J, Arlett CF, Green MH, Lowe J, Muriel W (1983) A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat Res 111:371–386
Applegate ML, Moore MM, Broder CB et al (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc Natl Acad Sci USA 87:51–55
Clements J (2000) The mouse lymphoma assay. Mutat Res 455:97–110
Liechty MC, Scalzi JM, Sims KR et al (1998) Analysis of large and small colony L5178Y tk−/− mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: detection of recombination. Mutagenesis 13:461–474
Honma M, Momose M, Sakamoto H, Sofuni T, Hayashi M (2001) Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction. Mutat Res 493:101–114
Wang J, Sawyer JR, Chen L et al (2009) The mouse lymphoma assay detects recombination, deletion, and aneuploidy. Toxicol Sci 109:96–105
FDA (2000) Redbook 2000: IV.C.1.c mouse lymphoma thymidine kinase gene mutation assay. http://wwwfdagov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredientsandPackaging/Redbook/ucm078336htm
Dearfield KL, Auletta AE, Cimino MC, Moore MM (1991) Considerations in the U.S. Environmental Protection Agency’s testing approach for mutagenicity. Mutat Res 258:259–283
ICH (1995) Topic S2A genotoxicity: guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals. In: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, harmonised tripartite guideline CPMP/ICH/141/95. Approved Sept 1995. http://www.ifpma.org/ich1.html
Muller L, Kikuchi Y, Probst G et al (1999) ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutat Res 436:195–225
ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). Approved Nov 2011. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf
OECD (1997) In vitro mammalian cell gene mutation test, OECD guideline for testing of chemicals, no. 476. http://wwwoecdorg/chemicalsafety/assessmentofchemicals/1948426pdf
Moore MM, Honma M, Clements J et al (2000) Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup Report. Environ Mol Mutagen 35:185–190
Moore MM, Honma M, Clements J et al (2002) Mouse lymphoma thymidine kinase gene mutation assay: follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000. Environ Mol Mutagen 40:292–299
Moore MM, Honma M, Clements J et al (2003) Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup report–Plymouth, UK 2002. Mutat Res 540:127–140
Moore MM, Honma M, Clements J et al (2006) Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing–Aberdeen, Scotland, 2003–assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 47:1–5
Moore MM, Honma M, Clements J et al (2007) Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment. Mutat Res 627:36–40
Moore MM, Honma M, Clements J et al (2011) Suitable top concentration for tests with mammalian cells: mouse lymphoma assay workgroup. Mutat Res 723:84–86
Hozier J, Sawyer J, Clive D, Moore M (1982) Cytogenetic distinction between the TK + and TK− chromosomes in the L5178Y TK+/− 3.7.2C mouse-lymphoma cell line. Mutat Res 105:451–456
Sawyer J, Moore MM, Clive D, Hozier J (1985) Cytogenetic characterization of the L5178Y TK+/−3.7.2C mouse lymphoma cell line. Mutat Res 147:243–253
Moore-Brown MM, Clive D, Howard BE, Batson AG, Johnson KO (1981) The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK−/−) mutants from L5178Y/TK+/− mouse lymphoma cells. Mutat Res 85:363–378
Clive D, Johnson KO, Spector JF, Batson AG, Brown MM (1979) Validation and characterization of the L5178Y/TK+/− mouse lymphoma mutagen assay system. Mutat Res 59:61–108
Moore MM, Clive D, Hozier JC et al (1985) Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells. Mutat Res 151:161–174
Moore MM, Clive D, Howard BE, Batson AG, Turner NT (1985) In situ analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells. Mutat Res 151:147–159
Clark LS, Harrington-Brock K, Wang J et al (2004) Loss of P53 heterozygosity is not responsible for the small colony thymidine kinase mutant phenotype in L5178Y mouse lymphoma cells. Mutagenesis 19:263–268
Brendler-Schwaab S, Czich A, Epe B et al (2004) Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutat Res 566:65–91
Mei N, Xia Q, Chen L, Moore MM, Fu PP, Chen T (2005) Photomutagenicity of retinyl palmitate by ultraviolet a irradiation in mouse lymphoma cells. Toxicol Sci 88:142–149
Mei N, Xia Q, Chen L, Moore MM, Chen T, Fu PP (2006) Photomutagenicity of anhydroretinol and 5,6-epoxyretinyl palmitate in mouse lymphoma cells. Chem Res Toxicol 19:1435–1440
Mei N, Hu J, Xia Q, Fu PP, Moore MM, Chen T (2010) Cytotoxicity and mutagenicity of retinol with ultraviolet A irradiation in mouse lymphoma cells. Toxicol In Vitro 24:439–444
Gocke E, Muller L, Guzzie PJ et al (2000) Considerations on photochemical genotoxicity: report of the International Workshop on Genotoxicity Test Procedures Working Group. Environ Mol Mutagen 35:173–184
Mei N, Chen T, Godar DE, Moore MM. UVA-induced photomutagenicity of retinyl palmitate. Mutat Res 2009;677:105–106; author reply 107–108
Lorge E (2013) Recommendations for good cell culture practices in genotoxicity testing. Genetic Toxicology Technical Committee, ILSI-HESI, Washington, DC (Personal Communication)
Machanoff R, O’Neill JP, Hsie AW (1981) Quantitative analysis of cytotoxicity and mutagenicity of benzo[a]pyrene in mammalian cells (CHO/HGPRT system). Chem Biol Interact 34:1–10
Majeska JB, Matheson DW (1990) Development of an optimal S9 activation mixture for the L5178Y TK+/− mouse lymphoma mutation assay. Environ Mol Mutagen 16:311–319
Honma M, Zhang LZ, Sakamoto H et al (1999) The need for long-term treatment in the mouse lymphoma assay. Mutagenesis 14:23–29
Acknowledgements
The authors thank Drs. Mugimane G. Manjanatha and Haixia Lin for the critical review of the manuscript. Use of trade names is for informational purposes only and in no way implies endorsement by the U.S. Food and Drug Administration (FDA). The views presented in this paper do not necessarily reflect those of the U.S. FDA.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Mei, N., Guo, X., Moore, M.M. (2014). Methods for Using the Mouse Lymphoma Assay to Screen for Chemical Mutagenicity and Photo-Mutagenicity. In: Caldwell, G., Yan, Z. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-742-6_34
Download citation
DOI: https://doi.org/10.1007/978-1-62703-742-6_34
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-741-9
Online ISBN: 978-1-62703-742-6
eBook Packages: Springer Protocols